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Introduction 
Clinical presentation: 
• Painful or pruritic wheals on trunk, proximal extremities, 
or face lasting > 24 hours
• purpura, ecchymosis, post-inflammatory 
hyperpigmentation
• Preceding upper respiratory tract infection or drug-
induced (penicillins and NSAIDs)
Differential: 
• Systemic lupus erythematosus, urticaria multiforme, 
Henoch-Schonlein purpura, cutaneous small-vessel 
vasculitis, and serum sickness-like syndrome. 
Characteristics: 
• Histology: Perivascular neutrophilic infiltrates, fibrinoid
deposits, and red blood cell extravasation
• Direct immunofluorescence: granular or linear immune




• Type III hypersensitivity reaction affecting dermal
capillaries and postcapillary venules
• Antigen-antibody complex deposition within vessel walls 
 complement activation  mast cell degranulation 
histamine release  neutrophil chemotaxis 
Epidemiology 
• Adults age 40-50, women > men
• Rare pediatric cases
Case Report 
Clinical presentation: 
• Red/purple painful rash x 1 month duration on shoulders, proximal arms, and
chest
• No significant past medical history including trauma, injury, illness, allergies, 
medications, surgeries 
• Family history negative for autoimmunity or malignancy
• No systemic symptoms (fevers, chills, cough, arthralgias, edema, urinary or
bowel changes)
Hospital admission: 
• CBC, UA, CMP, ESR, TSH/T4, iron studies, PT/PTT, HgB A1c,     LDH, and
reticulocyte count  WNL
• COVID-19 negative x 3
Primary care evaluation: 
• Medrol dose pack: no rash improvement 
Dermatology evaluation: 
• Biopsy: perivascular neutrophilic infiltrates and fibrin deposits
• Labs: c-ANCA, p-ANCA, RF, ANA, C4, C3, C1q, anti-C1q, CH50, Hepatitis 
panel, SPEP, ASO, and repeat UA all WNL. EBV and Parvovirus B19 panels 
indicative of prior infection, IgM negative
• Follow up: Eventual resolution of rash without recurrence
Discussion 
When to suspect UV:
• Pediatric patient presenting for urticarial lesions lasting
> 24 hours with purpura or hyperpigmentation and pain
Diagnosis: 
• Clinical suspicion and biopsy showing leukocytoclastic
vasculitis with perivascular inflammation, neutrophilic
infiltrates, and fibrinoid deposits
Prognosis: 
• Normocomplementemic:
• more mild disease course, typically skin-limited
• Favorable prognosis, few recurrences
• Hypocomplementemic:
• More severe and systemic illness
• Strongly associated with SLE
• May present with with arthritis, angioedema, uveitis,
episcleritis, abdominal pain, obstructive lung disease,
and glomerulonephritis
• Close follow-up for development or worsening of
pulmonary and renal disease
Treatment: 
• Cessation of offending agents ± treat underlying
conditions
• Swelling, urticaria, pain: antihistamines and NSAIDs
• Prolonged illness: oral steroids
• Recurrent or recalcitrant disease: indomethacin,
dapsone, colchicine, hydroxychloroquine,
mycophenolate mofetil, rituximab, anakinra, and
omalizumab
• Frequently self-limited without recurrence
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